Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine pretreatment doses for postoperative sore throat after double-lumen endobronchial intubation
ChiCTR2500110242Phase 4Recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in Post-extubation sore throat (POST) (4 arms), sponsored by Lishui People's Hospital. Primary endpoints: Incidence of postoperative sore throat and Severity of postoperative sore throat. Started Oct 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on ChiCTR2500110242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110242.